These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 26842910)
1. MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1). Zhao L; Wang Y; Jiang L; He M; Bai X; Yu L; Wei M J Exp Clin Cancer Res; 2016 Feb; 35():25. PubMed ID: 26842910 [TBL] [Abstract][Full Text] [Related]
2. miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells. Wang Y; Zhao L; Xiao Q; Jiang L; He M; Bai X; Ma M; Jiao X; Wei M Gynecol Oncol; 2016 Jun; 141(3):592-601. PubMed ID: 26644266 [TBL] [Abstract][Full Text] [Related]
3. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells. Hu D; Li M; Su J; Miao K; Qiu X Genet Test Mol Biomarkers; 2019 Mar; 23(3):156-165. PubMed ID: 30807260 [TBL] [Abstract][Full Text] [Related]
4. Combination of 7- Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024 [TBL] [Abstract][Full Text] [Related]
5. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. Li C; Guan X; Xue H; Wang P; Wang M; Gai X Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. Bao L; Hazari S; Mehra S; Kaushal D; Moroz K; Dash S Am J Pathol; 2012 Jun; 180(6):2490-503. PubMed ID: 22521303 [TBL] [Abstract][Full Text] [Related]
7. miRNA expression patterns in chemoresistant breast cancer tissues. Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164 [TBL] [Abstract][Full Text] [Related]
8. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway. Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933 [TBL] [Abstract][Full Text] [Related]
9. miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1. Gao M; Miao L; Liu M; Li C; Yu C; Yan H; Yin Y; Wang Y; Qi X; Ren J Oncotarget; 2016 Sep; 7(37):59714-59726. PubMed ID: 27487127 [TBL] [Abstract][Full Text] [Related]
10. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27 Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1. Li XJ; Ji MH; Zhong SL; Zha QB; Xu JJ; Zhao JH; Tang JH Arch Med Res; 2012 Oct; 43(7):514-21. PubMed ID: 23085450 [TBL] [Abstract][Full Text] [Related]
12. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. Zhong S; Li W; Chen Z; Xu J; Zhao J Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196 [TBL] [Abstract][Full Text] [Related]
13. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866 [TBL] [Abstract][Full Text] [Related]
14. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression. Zhou S; Li J; Xu H; Zhang S; Chen X; Chen W; Yang S; Zhong S; Zhao J; Tang J Gene; 2017 Jul; 622():1-12. PubMed ID: 28431975 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway. Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474 [TBL] [Abstract][Full Text] [Related]
16. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer. Chang L; Hu Z; Zhou Z; Zhang H Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527 [TBL] [Abstract][Full Text] [Related]
17. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2). Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685 [TBL] [Abstract][Full Text] [Related]
18. The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells. Zhu Y; Wu J; Li S; Ma R; Cao H; Ji M; Jing C; Tang J Cell Physiol Biochem; 2013; 32(5):1225-37. PubMed ID: 24335172 [TBL] [Abstract][Full Text] [Related]
19. miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A. Zhang Y; He Y; Lu LL; Zhou ZY; Wan NB; Li GP; He X; Deng HW Kaohsiung J Med Sci; 2019 Jan; 35(1):17-23. PubMed ID: 30844143 [TBL] [Abstract][Full Text] [Related]
20. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway. Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]